Victor S Goldmacher

Title: Victor S Goldmacher: Innovator in Cytotoxic Agents

Introduction

Victor S Goldmacher is a prominent inventor based in Newton Center, MA (US). He has made significant contributions to the field of cytotoxic agents, holding a total of 4 patents. His work focuses on developing therapeutic agents that target specific cell populations, which has important implications for cancer treatment.

Latest Patents

Goldmacher's latest patents include innovative formulations and methods for using maytansinoids. One of his notable patents describes a cytotoxic agent that comprises one or more maytansinoids linked to a cell binding agent. This agent is designed to kill selected cell populations effectively. Another patent details an N-methyl-alanine-containing ester of maytansinol, which includes a linking group that connects the maytansinoid ester to a chemical moiety. Additionally, he has developed methods for creating blocked lectins that can be used to target specific cells while minimizing toxicity to non-selected populations.

Career Highlights

Throughout his career, Goldmacher has worked with reputable organizations such as Immunogen, Inc. and Dana-Farber Cancer Institute. His research has significantly advanced the understanding and application of cytotoxic agents in therapeutic settings.

Collaborations

Goldmacher has collaborated with notable professionals in his field, including Ravi Chari and John M Lambert. These collaborations have contributed to the development of innovative solutions in cancer treatment.

Conclusion

Victor S Goldmacher's work in the field of cytotoxic agents showcases his dedication to advancing medical science. His patents and collaborations reflect a commitment to improving therapeutic options for patients.